Dracen Pharmaceuticals, Inc.
PrivateLast Round
Debt
Jul 27, 2023
Total Funding Raised
$61.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dracen Pharmaceuticals, Inc. is a biotechnology company that develops cancer treatment medicines intended to shrink tumors and remodel the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dracen Pharmaceuticals, Inc. Comparables
Compare Dracen Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoMet Therapeutics | 81% | |
| Cornerstone Pharmaceuticals, Inc. | 77% | |
| Rafael Holdings, Inc. | 76% | |
Dracen Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 27, 2023 | ||||
| Series A Extension | Mar 10, 2022 | ||||
| Series A Extension | Nov 1, 2021 | ||||
| Series A | Mar 22, 2018 |
Dracen Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
| Osage University Partners | Series A |
| i&i Prague | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 116% MoM, reaching 2K.
- Mar 22, 2018
$41M round led by Deerfield Management.
Dracen Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dracen Pharmaceuticals, Inc.'s valuation, stock price, and market status.